Cellmid Limited (ASX:CDY)
Cellmid Limited is an Australia-based health and beauty-tech business company. The Company is specialized in developing anti-aging solutions. The Company operates through two segments: Diagnostics and Consumer Health. The Company is engaged in the research and development of diagnostic and therapeutic products for the management of diseases, such as cancer and various chronic inflammatory conditions by targeting midkine. It is also engaged in the development and sale of over the counter (OTC) and cosmetic products for hair loss and anti-aging hair care through its FGF5 inhibitor technology. It has developed a range of products under the evolis, evolis Professional, Lexilis Hybrid, Jo-JuRED and Lexilis BLACK brands.